Aveta Biomics, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07667296) | Aveta Biomics, Inc. | 2026-07-01 |
| Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab (NCT06011109) | Aveta Biomics, Inc. | 2023-12-13 |
| Safety and Efficacy of APG-157 in Head and Neck Cancer (NCT05312710) | Aveta Biomics, Inc. | 2022-04-22 |
Track Aveta Biomics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.